The Effect of Positive End-Expiratory Pressure on Functional Residual Capacity During Mechanical Ventilation

May 28, 2020 updated by: Jian-Xin Zhou, Capital Medical University
Although positive end-expiratory pressure (PEEP) has been widely used in mechanical ventilated patients with acute respiratory distress syndrome (ARDS), how to select the "optimal" PEEP is far from consensus. The application of PEEP may result in beneficial effect by recruiting previously collapsed lung areas, harmful effect by over-distending previously aerated lung areas, or a combination of the both. The net effect of PEEP in a certain patient may depend on the recruitability. Because recruitability varies extremely in ARDS patients and strongly correlates with the response to PEEP, estimation of end-expiratory lung volume (EELV) may be essential for individualized setting of PEEP. Whether the FRC changes at different PEEP levels remains unknown.

Study Overview

Detailed Description

Although positive end-expiratory pressure (PEEP) has been widely used in mechanical ventilated patients with acute respiratory distress syndrome (ARDS), how to select the "optimal" PEEP is far from consensus. The application of PEEP may result in beneficial effect by recruiting previously collapsed lung areas, harmful effect by over-distending previously aerated lung areas, or a combination of the both. The net effect of PEEP in a certain patient may depend on the recruitability. Because recruitability varies extremely in ARDS patients and strongly correlates with the response to PEEP, estimation of end-expiratory lung volume (EELV) may be essential for individualized setting of PEEP.

Passive spirometry has long been used to measure the lung recruitment volume (VREC). A prolonged expiration to zero end-expiratory pressure (ZEEP) or airway release maneuver is required and PEEP induced lung volume change above functional residual capacity (FRC) is measured. This technique assumes that FRC does not change at different PEEP levels.

This assumption that PEEP has no effect on FRC can date back to the study of Valta et al in the early 1990s. Using respiratory inductive plethysmography (RIP), they found that in ALI/ARDS patients, after expiring from different PEEP levels to ZEEP, the plethysmography signal returned to the same baseline value. They concluded that FRC does not change with PEEP, and that changes of EELV are attributable only to change in ∆EELV. Ranieri et al arrived at similar conclusions by measuring differences in lung volumes at different PEEP levels using standardized pressure-volume (P-V) curves derived from the ventilator circuit monitors. However, Patroniti et al found an elevation of FRC as increasing of PEEP in patients with ARDS. In this study, FRC was measured with the helium dilution technique, and concluded that neglecting this effect resulted in marked underestimation of VREC. Whether the FRC changes at different PEEP levels remains controversial. The aim of the study is to assess the effect of PEEP on FRC during mechanical ventilation.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100050
        • Jian-Xin Zhou

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria include:

  1. Diagnosed with ARDS according to the Berlin Definition;
  2. Age 18-80 years;
  3. Ventilated with volume-controlled ventilation using constant flow;
  4. Deep sedation (RASS -4 to -5) and absence of spontaneous breathing (i.e., no triggering during tidal breaths and no inspiratory effort during a 5-second end-expiratory hold).

Exclusion criteria include:

  1. Evidence of active air leak from the lung, including bronchopleural fistula, pneumothorax, pneumomediastinum, or existing chest tube;
  2. Chest wall and/or abdominal injuries;
  3. Evidence suggesting reduced chest wall compliance, such as existing large pleural effusion, thoracic trauma and intra-abdominal hypertension (i.e., intra-abdominal pressure > 20 mmHg).
  4. Presence of pacemaker, defibrillator, and implantable pumps).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: FRC at clinical PEEP level
Measuring FRC at clinical PEEP level
Two PEEP levels will be used during mechanical ventilation.
Experimental: FRC at clinical PEEP + 5cmH2O
Increasing PEEP to clinical PEEP + 5cmH2O
Two PEEP levels will be used during mechanical ventilation.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of FRC
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
EELV measurement by ICU ventilator; PEEP Volume measured through airway release. FRC will be calculated as EELV minus PEEP volume. Correlation between EELV, PEEP volume, FRC at two different PEEP levels are tested by linear regression analysis.
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The change of PaO2/FiO2 Ratio
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
Obtaining PaO2 according to blood gas analysis, and FiO2 according to the ventilator
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of regional EELV
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
Regional EELV will be measured at clinical PEEP and clinical PEEP +5cmH2O
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of homogeneity of distribution of tidal volume
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
EIT is used to monitoring the homogeneity of distribution of tidal volume that was divided into two contiguous regions of interest (ROI) equally, the dependent and non-dependent area. The ratio of relative distribution of tidal ventilation of two ROI was calculated.
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of driving Pressure
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of driving pressure will be measured.
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of regional FRC
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
Regional FRC will be measured at clinical PEEP and clinical PEEP +5cmH2O
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of blood pressure
Time Frame: 1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O
The change of blood pressure will be measured
1) One hour after using clinical PEEP 2) One hour after using clinical PEEP + 5cmH2O

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jian-Xin Zhou, MD, Beijing Tiantan Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 1, 2020

Primary Completion (Anticipated)

February 28, 2021

Study Completion (Anticipated)

March 31, 2021

Study Registration Dates

First Submitted

April 8, 2018

First Submitted That Met QC Criteria

April 26, 2018

First Posted (Actual)

April 30, 2018

Study Record Updates

Last Update Posted (Actual)

May 29, 2020

Last Update Submitted That Met QC Criteria

May 28, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe